Skip to content

Depression: all studies

Page 318 of 1,036: studies 3,171 to 3,180 of 10,358, newest first. Back to the depression overview

Research

Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.

Journal of Palliative Medicine July 2010 Scott A Irwin, Alana Iglewicz

Depression is prevalent and undertreated in patients receiving hospice care. Standard antidepressants do not work rapidly or often enough to benefit most of these patients. Here, two cases are reported in which a single oral dose of ketamine provided rapid and moderately sustained symptom relief for both depression and anxiety. In addition, no adverse effects were noted. Further investigation...

Experiential Avoidance, Mindfulness and Depression in Spinal Cord Injuries: A Preliminary Study

The Australian Journal of Rehabilitation Counselling May 1, 2010 Timothy C. Skinner, Terri Roberton, Garry T. Allison et al.

Abstract: This preliminary study sought to explore the link between depression, experiential avoidance and mindfulness in people with a spinal cord injury (SCI). We surveyed patients listed on the SCI database at Royal Perth Hospital who had experienced an injury over the last 10 years. Respondents (62) completed a questionnaire including the depression subscale of the Depression Anxiety Stress...

Effects of mindfulness based stress reduction program on depression, anxiety and stress in patients with aneurysmal subarachnoid hemorrhage.

Journal of Korean Neurosurgical Society May 2010 Hye Myung Joo, Sung Jae Lee, Yong Gu Chung et al.

In this study, the Mindfulness Based Stress Reduction (MBSR) program was applied to patients presenting with depression and anxiety after surgery from spontaneous subarachnoid hemorrhage (SAH) and the effects were assessed. The subjects were patients admitted for cerebral aneurysm rupture and treated by means of surgery from March to December, 2007. More than 6 months had passed after surgery,...

Staying well after depression: trial design and protocol

BMC Psychiatry April 30, 2010 S Duggan Danielle, J Whitaker Chris, Russell Daphne et al.

Abstract Background Depression is often a chronic relapsing condition, with relapse rates of 50-80% in those who have been depressed before. This is particularly problematic for those who become suicidal when depressed since habitual recurrence of suicidal thoughts increases likelihood of further acute suicidal episodes. Therefore the question how to prevent relapse is of particular urgency in...

Innovative approaches to treatment - refractory depression: The ketamine story

Indian Journal of Psychiatry April 1, 2010 T. Rao, Chittaranjan Andrade

Byline: T.S. Rao, Chittaranjan. Andrade Antidepressant drugs have traditionally addressed the monoamine triumvirate: serotonin, noradrenaline, and dopamine. There have been predominantly two mechanisms recruited in drug action - inhibition of monoamine reuptake and inhibition of intravesicular monoamine catabolism. Tianeptine, which increases the synaptic reuptake of serotonin, and mirtazapine,...

The Effect of Mindfulness-Based Therapy on Anxiety and Depression: A Meta-Analytic Review

Journal of Consulting and Clinical Psychology April 1, 2010 Stefan G Hofmann, Alice T. Sawyer, Ashley A. Witt et al.

BACKGROUND Although mindfulness-based therapy has become a popular treatment, little is known about its efficacy. OBJECTIVES To conduct an effect size analysis of this popular intervention for anxiety and mood symptoms in clinical samples. DATA SOURCES A literature search was conducted using PubMed, PsycInfo, the Cochrane Library, and manual searches. REVIEW METHODS The search identified 39...